Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Chao MP, Hong J, Kunder C, Lester L, Schrier SL, Majeti R.

Am J Hematol. 2015 Jan;90(1):78-81. doi: 10.1002/ajh.23791. Epub 2014 Jul 11. No abstract available.

2.

Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Wouters D, Zeerleder S.

Haematologica. 2015 Nov;100(11):1388-95. doi: 10.3324/haematol.2015.128538. Review.

3.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538
4.

Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.

Ajmi H, Mabrouk S, Hassayoun S, Regaieg H, Tfifha M, Jalel C, Skouri H, Zouari N, Abroug S.

J Med Case Rep. 2017 Nov 14;11(1):321. doi: 10.1186/s13256-017-1449-2.

5.

L6. Eosinophilic granulomatosis with polyangiitis: future therapies.

Moosig F.

Presse Med. 2013 Apr;42(4 Pt 2):510-2. doi: 10.1016/j.lpm.2013.01.006. Epub 2013 Feb 28. Review. No abstract available.

PMID:
23453508
6.

Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment.

Morselli M, Luppi M, Potenza L, Tonelli S, Dini D, Leonardi G, Donelli A, Narni F, Torelli G.

Blood. 2002 May 1;99(9):3478-9. No abstract available.

7.

Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.

So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B.

Mod Rheumatol. 2014 Sep;24(5):855-7. doi: 10.3109/14397595.2013.874740. Epub 2014 Feb 11.

PMID:
24517558
9.

Severe autoimmune hemolytic anemia associated with IgM warm auto-antibodies in primary Sjögren's syndrome.

Shinoda K, Taki H, Hounoki H, Ogawa R, Sugiyama E, Tobe K.

Int J Rheum Dis. 2010 Feb 1;13(1):94-6. doi: 10.1111/j.1756-185X.2009.01450.x.

PMID:
20374393
10.

Fatal immune hemolytic anemia and hepatic failure associated with a warm-reacting IgM autoantibody.

Shirey RS, Kickler TS, Bell W, Little B, Smith B, Ness PM.

Vox Sang. 1987;52(3):219-22.

PMID:
3604181
11.

Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.

Umezawa N, Kohsaka H, Nanki T, Watanabe K, Tanaka M, Shane PY, Miyasaka N.

Mod Rheumatol. 2014 Jul;24(4):685-7. doi: 10.3109/14397595.2013.874734. Epub 2014 Feb 11.

PMID:
24517553
12.

[The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].

Liu H, Xing LM, Wang HQ, Wu YH, Qu W, Liang Y, Wang GJ, Song J, Wang XM, Guan J, Li LJ, Fu R, Shao ZH.

Zhonghua Nei Ke Za Zhi. 2012 Jun;51(6):456-9. Chinese.

PMID:
22943757
13.

Accessory splenules in autoimmune hemolytic anemia.

Logan A, Berube C, Gotlib J.

Am J Hematol. 2013 Feb;88(2):156. doi: 10.1002/ajh.23335. Epub 2012 Oct 1. No abstract available.

14.

Rituximab for treatment of autoimmune hemolytic anemia.

Kuzmanovic M, Jurisic V.

Indian Pediatr. 2012 Aug;49(8):672-4.

15.

[CME. Biologics in vasculitis].

Scharl M, Schaer D, Vallelian F.

Praxis (Bern 1994). 2015 Jan 2;104(1):7-16; quiz 15. doi: 10.1024/1661-8157/a001876. German. No abstract available. Erratum in: Praxis (Bern 1994). 2015 Jan 28;104(3):116.

PMID:
25552441
16.

Anti B cell targeted therapy for autoimmune hemolytic anemia in an infant.

Makadia D, Siddaiahgari SR, Latha MS.

Indian J Pharmacol. 2013 Sep-Oct;45(5):526-7. doi: 10.4103/0253-7613.117755.

17.

Rituximab in the treatment of autoimmune haemolytic anaemia.

Rodrigo C, Rajapakse S, Gooneratne L.

Br J Clin Pharmacol. 2015 May;79(5):709-19. doi: 10.1111/bcp.12498. Review.

18.
19.

[Are intravenous immunoglobulins useful in severe episodes of autoimmune hemolytic anemia?: Comparative results in 21 episodes from a single centre].

Gil-Fernández JJ, Flores Ballester E, González Martínez M, Arévalo-Serrano J, Tamayo Martín AT, Burgaleta Alonso de Ozalla C.

Med Clin (Barc). 2013 Sep 7;141(5):201-4. doi: 10.1016/j.medcli.2012.05.030. Epub 2012 Aug 1. Spanish.

PMID:
22857805
20.

Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.

Bhattacharyya J, Mihara K, Takihara Y, Kimura A.

Ann Hematol. 2012 May;91(5):797-799. doi: 10.1007/s00277-011-1322-0. Epub 2011 Sep 8. No abstract available.

PMID:
21901341

Supplemental Content

Support Center